Literature DB >> 29545848

Protective function of Bu Shen Huo Xue formula on the immunity of B6AF1 mice with experimental autoimmune premature ovarian failure.

Peijuan Wang1,2, Yan Lu1,2, Si Chen1,2, Yue Chen1,2, Chunping Hu1,2, Yawei Zuo3.   

Abstract

Autoimmune abnormality is one of the main causes of premature ovarian failure (POF). Bu Shen Huo Xue formula (BSHXF), a traditional Chinese medicine formula, has been clinically used for the treatment of patients with POF in China. Regulatory T cells (Tregs) are important in the pathogenesis of autoimmune POF. The aim of the present study was to evaluate the immunoprotective effects of BSHXF on POF and the underlying mechanisms. An experimental autoimmune POF model was induced in B6AF1 mice with zona pellucida 3 (ZP3) fragments. Following modeling, BSHXF (31.53 g/kg/day) was orally administered for 4 weeks. CD4+ T lymphocytes, Tregs, anti-zona pellucida (anti-ZP) antibodies and cytokines were detected using flow cytometry, enzyme-linked immunosorbent assays, reverse transcription-quantitative polymerase chain reaction and immunohistochemistry. The results revealed that BSHXF exhibited an immunoprotective function and reduced inflammatory cell infiltration and damage to the ovary. BSHXF upregulated the percentage of CD4+ CD25+ forkhead box P3+ T cells in the spleen, effectively inhibiting the activation of CD4+ T lymphocytes. The proliferation of Tregs was increased in serum obtained from mice in the BSHXF group in vitro. Anti-ZP antibodies and interleukin-10 and interferon-γ levels were decreased in the serum in the BSHXF-treated group. The present study demonstrated that BSHXF had an immunoprotective effect on POF model mice. Additionally, it indicated that the protective mechanisms of BSHXF may be associated with an increase in Treg cells.

Entities:  

Keywords:  Bu Shen Huo Xue formula; CD4+ T lymphocyte; experimental autoimmune premature ovarian failure; protective immunity effect; regulatory T cells

Year:  2018        PMID: 29545848      PMCID: PMC5840928          DOI: 10.3892/etm.2018.5804

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling.

Authors:  Janice Chen; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 3.  Long term hormone therapy for perimenopausal and postmenopausal women.

Authors:  Cindy Farquhar; Jane Marjoribanks; Anne Lethaby; Jane A Suckling; Quirine Lamberts
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

4.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

5.  Immune disorders in women with premature ovarian failure in initial period.

Authors:  V P Chernyshov; T V Radysh; I V Gura; T P Tatarchuk; Z B Khominskaya
Journal:  Am J Reprod Immunol       Date:  2001-09       Impact factor: 3.886

6.  Therapeutic effect of Bushen Huoxue recipe on autoimmune premature ovarian failure mice established by immunization with recombinant porcine zona pellucida 4 antigen.

Authors:  Chuan-ling Tang; Fang Li; Lan Sun; Da-jin Li
Journal:  Chin J Integr Med       Date:  2012-03-14       Impact factor: 1.978

7.  Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

Authors:  Shao-Ping Liu; Wei-Guo Dong; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

8.  Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida.

Authors:  S H Rhim; S E Millar; F Robey; A M Luo; Y H Lou; T Yule; P Allen; J Dean; K S Tung
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

9.  Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1).

Authors:  Riham Soliman Said; Ebtehal El-Demerdash; Ahmed Shafik Nada; Mohamed M Kamal
Journal:  Biochem Pharmacol       Date:  2016-01-28       Impact factor: 5.858

10.  Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III).

Authors:  Aristo Vojdani; Jonathan Erde
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-05       Impact factor: 2.629

View more
  8 in total

Review 1.  Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.

Authors:  Oldouz Shareghi-Oskoue; Leili Aghebati-Maleki; Mehdi Yousefi
Journal:  Stem Cell Res Ther       Date:  2021-08-11       Impact factor: 8.079

2.  Protective Effects and Possible Mechanisms of Actions of Bushen Cuyun Recipe on Diminished Ovarian Reserve Induced by Cyclophosphamide in Rats.

Authors:  Mei Jiang; Weiling Wang; Jingxuan Zhang; Chunguo Wang; Yucong Bi; Pin Li; Song Yang; Jialin Li; Yan-Tong Xu; Ting Wang
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

3.  The effects of human umbilical cord-derived mesenchymal stem cell transplantation on endometrial receptivity are associated with Th1/Th2 balance change and uNK cell expression of uterine in autoimmune premature ovarian failure mice.

Authors:  Xueyan Lu; Jingjing Cui; Linlu Cui; Qianqian Luo; Qizhi Cao; Wendan Yuan; Hongqin Zhang
Journal:  Stem Cell Res Ther       Date:  2019-07-22       Impact factor: 6.832

Review 4.  Research Progress on the Treatment of Premature Ovarian Failure Using Mesenchymal Stem Cells: A Literature Review.

Authors:  Jing Wang; Wanru Liu; Dehai Yu; Zongxing Yang; Sijie Li; Xiguang Sun
Journal:  Front Cell Dev Biol       Date:  2021-12-13

5.  Effectiveness and safety of Bushen Huoxue granules in treatment of premature ovarian insufficiency: study protocol for a randomized, double-blinded, placebo-controlled, and multicenter clinical trial.

Authors:  Ying Cao; Yan Lu; Yue Chen; Si Chen
Journal:  Trials       Date:  2021-12-04       Impact factor: 2.279

6.  Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency.

Authors:  Ying Cao; Yue Chen; Peijuan Wang; Jialin Lu; Xuan Han; Jingyao She
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 7.  Current Research on Complementary and Alternative Medicine in the Treatment of Premature Ovarian Failure: An Update Review.

Authors:  Yue Li; Meng-Yu Yan; Qiao-Chu Chen; Ya-Ya Xie; Chen-Yu Li; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-23       Impact factor: 2.650

Review 8.  Therapeutic Potential of HUMSCs in Female Reproductive Aging.

Authors:  Qiaojuan Mei; Hongbei Mou; Xuemei Liu; Wenpei Xiang
Journal:  Front Cell Dev Biol       Date:  2021-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.